跳至主要内容
临床试验/NCT04363528
NCT04363528已完成不适用

Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

Versailles Hospital2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2020年4月24日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
50
试验地点
2
主要终点
Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

研究概览

简要总结

The main objective of the study is to determine the incidence of deep vein thromboses at Doppler echo in patients with SARS-Cov-2 pneumopathy upon their entry into ICU and after 7 days of hospitalization in ICU.

This is a monocentric interventional study (RIPH 2).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patient > or =18 years
  • Hospitalization in intensive care
  • PCR COVID 19+ or compatible clinical signs (fever, cough, myalgia, asthenia, loss of taste, anosmia) associated with compatible radiological signs

排除标准

  • Pregnancy in progress
  • Patient <18 years
  • Patients deprived of freedoms or under guardianship
  • Patient or family opponent of protocol participation
  • patient on curative anticoagulant for more than 48H00
  • impossible Venous Doppler Echo

结局指标

主要结局

Incidence of Deep Vein Thrombosis at Doppler Echo in Patients With SARS-Cov-2 Pneumopathy Hospitalized in ICU

时间窗: Day 7

Deep vein thrombosis at Doppler echo

次要结局

未报告次要终点

研究者

发起方
Versailles Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

Aurelien Maurizot

coordonator investigator

Versailles Hospital

研究点 (2)

Loading locations...

相似试验